About company

Alucent Biomedical is developing a potential breakthrough combination drug-device therapy for a vascular disease called Natural Vascular Scaffolding (NVS). NVS is a first-of-a-kind combination drug-device therapy designed to assist the body in naturally opening and maintaining arterial patency. Alucent Biomedical is founded in Shaanxi, China.

Unknown
Unknown
Unknown
Not verified company